Discover the Divis Labs Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...

Shares of Divis Laboratories rose 3 percent to Rs 6,188 on Friday, August 22, after global brokerage Citi turned upbeat on the stock, flagging attractive valuations and sector tailwinds. Citi ...

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an announcement. Divi’s Laboratories Limited has announced that it will close its ...

HYDERABAD, Feb 3 (Reuters) - India's Divi's Laboratories (DIVI.NS), opens new tab reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses ...

shares of Divis Laboratories moved up by 2.11 percent to Rs 6281.50 in early trade. At 09:50 am, the stock is trading among the top gainers on Nifty Next 50. The company has demonstrated consistent ...

Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...